In Vivo CAR T-Cell Therapeutics With Umoja Biopharma’s Dr Andrew Scharenberg Dan In Vivo CAR T-Cell Therapeutics With Umoja Biopharma’s Dr Andrew Scharenberg Read More »
Next-Gen Immunotherapies for Cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma Dan Next-Gen Immunotherapies for Cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma Read More »
How is an increased focus on patient-centric concerns influencing the way that you work? Dan How is an increased focus on patient-centric concerns influencing the way that you work? Read More »
Confronting Challenges in Developing Cell and Gene Therapies Dan Confronting Challenges in Developing Cell and Gene Therapies Read More »
Umoja wants to move CAR T beyond the ‘Goldilocks patients’ Dan Umoja wants to move CAR T beyond the ‘Goldilocks patients’ Read More »